SWM1 Antibody

What is SWM1/Apc13 and what are its primary cellular functions?

SWM1/Apc13 is a small subunit of the anaphase-promoting complex/cyclosome (APC/C), a large ubiquitin-protein ligase that controls progression through anaphase by triggering the degradation of cell cycle regulators such as securin and B-type cyclins. This complex contains at least 10 different evolutionarily conserved components . SWM1/Apc13 specifically promotes the stable association of the essential subunits Cdc16 and Cdc27 with the APC/C . This function is critical for the complex's ubiquitin ligase activity in vitro and for the timely execution of APC/C-dependent cell cycle events in vivo .

The APC/C plays multiple roles throughout the cell cycle, including preventing precocious accumulation of mitotic cyclins during G1, creating an extended period of low Cdk1 activity . The complex targets various substrates including mitotic kinases, proteins controlling spindle behavior, and regulators of DNA replication . SWM1/Apc13's evolutionary conservation across species highlights its fundamental importance in cellular regulation.

How do SWM1/Apc13 homologs differ between species and what implications does this have for antibody selection?

SWM1/Apc13 has been identified in various organisms including budding yeast, fission yeast, and humans, suggesting evolutionary conservation of this protein . Functional complementation experiments have demonstrated that both human and fission yeast homologs can rescue the phenotype of budding yeast SWM1 deletion mutants . This conservation indicates that the protein performs similar fundamental roles across eukaryotic species.

When selecting antibodies for cross-species research, researchers should consider:

• Epitope conservation: Despite functional conservation, there may be sequence variations that affect antibody recognition. Verify the conservation of the epitope targeted by your antibody across the species of interest.

• Validation requirements: Each antibody should be validated in the specific species being studied, even if reported to work in related organisms.

• Post-translational modifications: Different species may exhibit distinct patterns of post-translational modifications on SWM1/Apc13, potentially affecting antibody binding.

What methodological approaches can distinguish between free SWM1/Apc13 and protein incorporated into the APC/C complex?

To differentiate between free SWM1/Apc13 and the protein incorporated into APC/C complexes, consider these methodological approaches:

• Size exclusion chromatography:

  • Separate protein complexes based on molecular size

  • Analyze fractions by Western blot with SWM1 antibodies

  • APC/C-incorporated SWM1/Apc13 will appear in high molecular weight fractions

  • Free SWM1/Apc13 will elute in later fractions corresponding to its lower molecular weight

• Sucrose density gradient centrifugation:

  • Layer cell lysate onto a 10-40% sucrose gradient

  • After ultracentrifugation, collect fractions and analyze by immunoblotting

  • Compare SWM1/Apc13 distribution with known APC/C components (e.g., Cdc16, Cdc27)

• Co-immunoprecipitation analysis:

  • Immunoprecipitate with antibodies against core APC/C components

  • Quantify the percentage of total SWM1/Apc13 that co-precipitates

  • The non-precipitated fraction may represent free SWM1/Apc13

• Blue native PAGE:

  • Separate native protein complexes by electrophoresis

  • Transfer to membrane and probe with SWM1 antibodies

  • Distinguish complex-incorporated from free protein based on migration patterns

How can I optimize immunoprecipitation protocols for studying SWM1/Apc13 interactions with other APC/C components?

For optimal immunoprecipitation (IP) of SWM1/Apc13 and its interacting partners within the APC/C complex, implement the following protocol:

• Lysis buffer selection:

  • Use gentle lysis conditions to preserve protein-protein interactions

  • Recommended buffer: 50mM HEPES pH 7.5, 150mM NaCl, 1mM EDTA, 1% NP-40, 10% glycerol, supplemented with protease inhibitors

• Pre-clearing step:

  • Pre-clear cell lysates with protein A/G beads for 1 hour at 4°C to reduce non-specific binding

• Antibody binding:

  • Incubate pre-cleared lysate with SWM1 antibody (2-5μg per mg of total protein) overnight at 4°C with gentle rotation

  • Add protein A/G beads and incubate for an additional 2-3 hours

• Washing conditions:

  • Perform 4-5 washes with lysis buffer containing reduced detergent (0.1% NP-40)

  • Include a final wash with detergent-free buffer

• Elution options:

  • For Western blot analysis: elute directly in SDS-PAGE loading buffer

  • For mass spectrometry: consider gentle elution with peptide competition or low-pH glycine buffer

When studying SWM1/Apc13's role in promoting the association of Cdc16 and Cdc27 with the APC/C , perform reciprocal IPs with antibodies against these subunits to confirm interactions. This approach helps validate the specificity of observed interactions and provides insight into complex assembly.

What controls should be included when performing Western blots with SWM1 antibodies?

When conducting Western blot analysis with SWM1 antibodies, include these essential controls:

• Negative controls:

  • SWM1 knockout/knockdown sample

  • Secondary antibody-only control to detect non-specific binding

  • Pre-immune serum control if using polyclonal antibodies

• Positive controls:

  • Recombinant SWM1 protein at known concentration

  • Samples with verified high SWM1 expression

  • Cell cycle synchronized samples (as SWM1/Apc13 may show cell cycle-dependent expression)

• Loading controls:

  • Standard housekeeping proteins (β-actin, GAPDH, tubulin)

  • Total protein stain (Ponceau S or SYPRO Ruby) for normalization

• Specificity validation:

  • Peptide competition assay to confirm antibody specificity

  • Multiple cell lines/tissues with expected expression patterns

Given that SWM1/Apc13 promotes the association of Cdc16 and Cdc27 with the APC/C , consider probing the same membrane for these proteins to correlate their expression levels with SWM1/Apc13, providing functional context for your observations.

How can SWM1 antibodies be used to investigate cell cycle regulation in different experimental systems?

SWM1 antibodies can be employed across various experimental systems to investigate cell cycle regulation:

• Cell synchronization studies:

  • Track SWM1/Apc13 expression across synchronized cell populations

  • Collect samples at defined intervals following synchronization

  • Process for both Western blot and immunofluorescence

  • Co-stain with cell cycle markers (e.g., phospho-histone H3 for mitosis)

  • Quantify relative protein levels across time points

• Genetic manipulation approaches:

  • In knockout/knockdown systems, assess changes in cell cycle progression

  • Use SWM1 antibodies to confirm protein depletion

  • In complementation studies, verify expression of exogenous SWM1/Apc13

• Comparative analyses:

  • Compare SWM1/Apc13 complex formation between normal and disease states

  • Assess potential correlation with proliferation rates or treatment responses

Since SWM1/Apc13 influences APC/C activity by promoting the association of specific subunits , these experiments can provide insights into the temporal regulation of this complex during cell cycle progression.

How can phosphorylation states of SWM1/Apc13 be assessed and what functional significance might they have?

Investigating SWM1/Apc13 phosphorylation requires specialized methodological approaches:

• Phosphorylation detection methods:

  • Phospho-specific antibodies (if available for specific residues)

  • Phospho-protein staining with Pro-Q Diamond following SDS-PAGE

  • Phos-tag SDS-PAGE to retard phosphorylated protein migration

  • Lambda phosphatase treatment to compare migration patterns

• Mass spectrometry approaches:

  • Immunoprecipitate SWM1/Apc13 using validated antibodies

  • Perform tryptic digestion followed by LC-MS/MS analysis

  • Use titanium dioxide enrichment to concentrate phosphopeptides

  • Quantify phosphorylation using SILAC or TMT labeling across conditions

• Functional analysis of phosphorylation:

  • Generate phospho-mimetic (S/T→D/E) and phospho-deficient (S/T→A) mutants

  • Complement SWM1/Apc13-deficient cells with these mutants

  • Assess effects on:

    • APC/C complex formation

    • Interaction with Cdc16 and Cdc27

    • Cell cycle progression

    • Ubiquitination activity of APC/C

Understanding SWM1/Apc13 phosphorylation could reveal regulatory mechanisms controlling its role in promoting stable association of subunits within the APC/C complex , potentially explaining how this function is modulated during different cell cycle phases.

What experimental approaches can elucidate the structural basis for SWM1/Apc13 interactions with Cdc16 and Cdc27?

To investigate the structural basis of SWM1/Apc13 interactions with Cdc16 and Cdc27, consider these advanced experimental approaches:

• Protein-protein interaction mapping:

  • Yeast two-hybrid or mammalian two-hybrid assays with domain truncations

  • In vitro pull-down assays with recombinant protein fragments

  • Peptide arrays to identify specific binding motifs

• Structural biology techniques:

  • X-ray crystallography: Co-crystallize SWM1/Apc13 with interaction partners

  • Cryo-electron microscopy: Visualize APC/C architecture with and without SWM1/Apc13

  • NMR spectroscopy: Map binding interfaces through chemical shift perturbations

• Crosslinking mass spectrometry (XL-MS):

  • Use chemical crosslinkers to capture protein-protein interactions

  • Digest crosslinked complexes and analyze by mass spectrometry

  • Identify residues in close proximity to map interaction surfaces

• Mutagenesis strategies:

  • Alanine scanning mutagenesis of predicted interface residues

  • Charge reversal mutations to disrupt salt bridges

  • Creation of chimeric proteins to map domain-specific interactions

Since SWM1/Apc13 promotes the stable association of Cdc16 and Cdc27 with the APC/C , these approaches can reveal the molecular mechanism underlying this function and potentially identify targetable interfaces for experimental manipulation.

How can SWM1 antibodies be used in studying the dynamics of APC/C assembly and disassembly throughout the cell cycle?

SWM1 antibodies can be powerful tools for investigating APC/C dynamics throughout the cell cycle:

• Time-resolved immunoprecipitation:

  • Synchronize cells at specific cell cycle phases

  • Perform SWM1 immunoprecipitation at regular intervals

  • Analyze co-precipitating APC/C components by Western blot or mass spectrometry

  • Quantify relative amounts of associated proteins to track complex assembly/disassembly

• Proximity-based protein labeling:

  • Generate SWM1 fusion with BioID or APEX2

  • Identify proximal proteins at different cell cycle stages

  • Map temporal changes in the APC/C interactome

• Quantitative mass spectrometry:

  • Use antibodies to isolate APC/C complexes across the cell cycle

  • Employ SILAC, TMT, or label-free quantification

  • Create temporal profiles of complex composition

  • Identify assembly intermediates

• Analysis of post-translational modifications:

  • Track changes in SWM1/Apc13 modifications throughout the cycle

  • Correlate with complex assembly/disassembly events

These approaches can reveal how SWM1/Apc13's role in promoting the association of Cdc16 and Cdc27 with the APC/C might be regulated throughout the cell cycle, providing insights into the mechanisms controlling APC/C activity.

What are common pitfalls when using SWM1 antibodies and how can they be addressed?

When working with SWM1 antibodies, researchers may encounter several common challenges:

• Low signal intensity in Western blots:

  • Potential causes: Low protein expression, insufficient antibody concentration

  • Solutions:

    • Increase antibody concentration (try 2-5x recommended dilution)

    • Extend primary antibody incubation time (overnight at 4°C)

    • Use signal enhancement systems (e.g., biotin-streptavidin amplification)

    • Try different blocking reagents (BSA vs. non-fat milk)

    • Increase protein loading (up to 50-100μg per lane)

• Non-specific bands:

  • Potential causes: Cross-reactivity, degradation products, secondary antibody issues

  • Solutions:

    • Increase stringency of washing (higher salt concentration, longer washes)

    • Use monoclonal antibodies for higher specificity

    • Perform peptide competition assays to identify specific bands

    • Try different blocking agents to reduce background

• Immunoprecipitation inefficiency:

  • Potential causes: Epitope masking, low antibody affinity, harsh lysis conditions

  • Solutions:

    • Test multiple antibodies targeting different epitopes

    • Use crosslinking approaches to stabilize transient interactions

    • Optimize lysis buffer composition (detergent type and concentration)

    • Increase antibody amount and incubation time

Since SWM1/Apc13 promotes the association of specific subunits with the APC/C , some of these issues may be particularly relevant when studying complex formation under various experimental conditions.

How can researchers distinguish between non-specific binding and true low-level SWM1/Apc13 expression?

Distinguishing between non-specific binding and genuine low-level SWM1/Apc13 expression requires rigorous validation:

• Comprehensive controls framework:

  • Genetic negative control: Use SWM1/Apc13 knockout/knockdown samples

  • Peptide competition: Pre-incubate antibody with immunizing peptide

  • Secondary-only control: Omit primary antibody

  • Isotype control: Use non-specific antibody of same isotype and concentration

  • Positive control: Include sample with confirmed SWM1/Apc13 expression

• Validation through orthogonal methods:

  • Confirm protein expression using multiple antibodies targeting different epitopes

  • Correlate protein detection with mRNA levels (RT-qPCR)

  • Use tagged SWM1/Apc13 expression systems in parallel

• Cross-validation experimental design:

  • Co-localization with known APC/C components

  • Enrichment in expected subcellular compartments

  • Cell cycle-dependent expression pattern consistent with function

  • Co-immunoprecipitation with known interacting partners

Since SWM1/Apc13 promotes the association of specific APC/C subunits , correlation with these known interaction partners provides additional validation of specific detection.

What factors should be considered when selecting a SWM1 antibody for specific research applications?

When selecting SWM1 antibodies for research, consider these critical factors:

• Antibody type selection:

  • Monoclonal antibodies: Offer high specificity but recognize only a single epitope

  • Polyclonal antibodies: Recognize multiple epitopes, potentially increasing sensitivity

  • Recombinant antibodies: Provide consistent performance with reduced lot variation

• Application-specific validation:

  • Western blot: Confirm single band at expected molecular weight

  • Immunoprecipitation: Verify pull-down efficiency and specificity

  • Immunofluorescence: Assess subcellular localization pattern consistency

• Epitope considerations:

  • Know the target epitope location (N-terminal, C-terminal, internal)

  • Consider whether post-translational modifications might affect epitope recognition

  • For fusion proteins, ensure the antibody epitope isn't masked by tags

• Species compatibility:

  • Ensure the antibody recognizes SWM1/Apc13 in your model organism

  • Check for cross-reactivity data across species if performing comparative studies

Since SWM1/Apc13 promotes the association of specific subunits with the APC/C , antibodies targeting different regions may have varying impacts on complex assembly when used in functional studies.

How should researchers interpret changes in SWM1/Apc13 levels in relation to cell cycle progression?

When analyzing SWM1/Apc13 levels throughout the cell cycle, consider these interpretive frameworks:

• Quantitative analysis approach:

  • Normalize SWM1/Apc13 levels to appropriate loading controls

  • Plot relative expression against cell cycle markers

  • Compare with known APC/C substrates and regulators

  • Perform statistical analysis across multiple experiments

• Context-dependent interpretation:

  • Consider whether changes reflect protein abundance or complex incorporation

  • Correlate with APC/C activity measurements using substrate degradation assays

  • Assess co-expression patterns with Cdc16 and Cdc27, which interact with SWM1/Apc13

  • Evaluate potential post-translational modifications affecting detection

• Experimental validation strategies:

  • Use synchronized cell populations at defined cell cycle stages

  • Compare results across multiple cell types or organisms

  • Validate with complementary techniques (e.g., flow cytometry, live-cell imaging)

  • Perform genetic perturbation (e.g., cell cycle arrest, checkpoint activation)

Understanding the relationship between SWM1/Apc13 levels and its function in promoting the association of specific subunits with the APC/C provides insight into the regulation of this essential complex throughout the cell cycle.

What quantitative methods can best analyze SWM1/Apc13 interactions with the APC/C complex?

For quantitative analysis of SWM1/Apc13 interactions with the APC/C complex, implement these methodological approaches:

• Co-immunoprecipitation quantification:

  • Perform immunoprecipitation with SWM1 antibodies under standardized conditions

  • Quantify co-precipitating APC/C components by Western blot densitometry

  • Calculate interaction stoichiometry using calibration curves with recombinant proteins

  • Apply statistical analysis across biological replicates

• Fluorescence-based interaction quantification:

  • Microscale thermophoresis to measure binding affinities

  • Fluorescence correlation spectroscopy for in-solution binding kinetics

  • FRET-based assays for proximity measurements

  • Biolayer interferometry for real-time binding kinetics

• Mass spectrometry-based quantification:

  • SILAC labeling to compare interaction partners across conditions

  • Selected reaction monitoring (SRM) for targeted quantification

  • Label-free quantification with appropriate normalization

  • iBAQ or Top3 methods for stoichiometry determination

This quantitative data can provide mechanistic insights into how SWM1/Apc13 promotes the stable association of Cdc16 and Cdc27 with the APC/C , potentially revealing regulatory mechanisms that control complex assembly.